This compound is not a standard chemical substance and appears to be a misnomer or a confusion between a biological target (huCXCR1, a human chemokine receptor) and a cell line (HCT116, a human colorectal cancer cell line). As such, it does not represent a chemical with defined applications in the traditional sense. However, in research contexts, the interaction between huCXCR1 and HCT116 cells is studied to understand cancer progression, particularly in colorectal cancer. Scientists investigate CXCR1 signaling in HCT116 cells to explore mechanisms of tumor growth, metastasis, and inflammation. This research supports the development of targeted therapies, including inhibitors of chemokine receptors, which may help block cancer cell survival and improve treatment outcomes.